Patients had elevated levels of acute-phase parameters, the majority of patients were positive for RF IgM (80% of patients from the group with early RA and 81.7% from the group with advanced RA) and for anti-CCP (92.2 and 85.2%, respectively). The gene discussed is CD40LG; the disease is rheumatoid arthritis.